Oral anticoagulant treatment: Risk factors involved in 500 intracranial hemorrhages

Journal of Thrombosis and Thrombolysis

Volumn 22, Issue 2, 2006, Pages 113-120

  Cantalapiedra, A ^a   Gutierrez, O ^a   Tortosa, J I ^a   Ya1nez M ^a   Duenas M ^a   Fernandez Fontecha, E ^a   Penarrubia M J ^a   Garcia Frade L J ^a  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

Anticoagulation treatment; Antiplatelet treatment; Cerebral bleeding; Risk factors

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 7A; CLOPIDOGREL; DIPYRIDAMOLE; ENOXAPARIN; FRESH FROZEN PLASMA; HEPARIN; NAPROXEN; PROTHROMBIN COMPLEX; RECOMBINANT PLASMINOGEN ACTIVATOR; TRIFLUSAL; VITAMIN K GROUP;

ADOLESCENT; AGE; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD DISEASE; BRAIN HEMORRHAGE; CANCER; CEREBELLUM HEMORRHAGE; CONGENITAL BLOOD VESSEL MALFORMATION; DRUG FATALITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; INJURY; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; RISK MANAGEMENT; SCHOOL CHILD; SPAIN; STATISTICAL SIGNIFICANCE; STROKE; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; TREATMENT INDICATION; VALVULAR HEART DISEASE;

EID: 33749188091     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-8455-3     Document Type: Article

References (60)

1. Hirsh J, Albers G, Guyatt G et al (2004) The seventh ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians. Chest 126:163S-696S
2. Aguilar MI, Hart R (2005) Oral anticoagulants for preventing stroke in patients with non valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 20(3)
3. Dhond AJ, Michelena HI, Ezekowitz MD (2003) Anticoagulation in the elderly. Am J Geriatr Cardiol 12:243-250
4. Barnett HJ (2002) Stroke prevention in the elderly. Clin Exp Hypertens 24:563-571
5. Chatap G, Giraud K, Vincent JP (2002) Atrial fibrillation in the elderly: Facts and management. Drugs Aging 19:819-846
6. Jackson SL, Peterson GM, Vial JH, Daud R, Ang SY (2001) Outcomes in the management of atrial fibrillation: Clinical trial results can apply in practice. Intern Med J 31:329-336
7. Gage BF, Fihn SD, White RH (2001) Warfarin therapy for an octogenarian who has atrial fibrillation. Ann Intern Med 134:465-474
8. Howard PA (1999) Guidelines for stroke prevention in patients with atrial fibrillation. Drugs 58:997-1009
9. Berwaerts J, Robb OJ, Jeffers TA, Webster J (2000) Intracerebral haemorrhages and oral anticoagulation in the north of Scotland. Scott Med J 45:101-104
10. Anderson CS, Chakera TM, Stewart-Wynne EG, Jamrozik KD (1994) Spectrum of primary intracerebral haemorrhage in Perth, Western Australia, 1989-1990: Incidence and outcome. J Neurol Neurosurg Psychiatry 57:936-940
11. Nicolini A, Ghirarduzzi A, Iorio A, Silingardi M, Malferrari G, Baldi G (2002) Intracranial bleeding: Epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia. Haematologica 87:948-956
12. Hart RG, Tonarelli SB, Pearce LA (2005) Avoiding central nervous system bleeding during antithrombotic therapy: Recent data and ideas. Stroke 36:1588-1593
13. Rodriguez Campello A, Roquer Gonzalez J, Gomis Cortina M, Munteis Oliva E, Ois Santiago A, Herraiz Rocamora J (2005) Cerebral hemorrhage in patients treated with oral anticoagulation. Rev Neurol 40:19-22
14. Beyth RJ, Landefeld CS (1995) Anticoagulants in older patients. A safety perspective. Drugs Aging 6:45-54
15. Mena-Martin FJ, Martin-Escudero JC, Simal-Blanco F, Carretero-Ares JL, Arzua-Mouronte D, Herreros-Fernandez V (2003) Health-related quality of life of subjects with known and unknown hypertension: Results from the population-based Hortega study. J Hypertens 21:1283-1289
16. Berwaerts J, Dijkhuizen RS, Robb OJ, Webster J (2000) Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage. Stroke 31:2558-2562
17. Gullov AL, Koefoed BG, Petersen P (1999) Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: The AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. Arch Intern Med 159:1322-1328
18. Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H (2002) Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347:969-974
19. Yañez M, Cantalapiedra A, Peñarrubia MJ, García Frade LJ (2001) Central nervous system haemorhages and relationship to oral anticoagulation. J Thromb Haemost; 86s: Abstract CD number 3622
20. Levine MN, Raskob G, Hirsh J (1985) Risk of haemorrhage associated with long-term anticoagulant therapy. Drugs 30:444-460
21. Berwaerts J, Webster J (2000) Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages. QJM 93:513-521
22. Launbjerg J, Egeblad H, Heaf J, Nielsen NH, Fugleholm AM, Ladefoged K (1991) Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients. J Intern Med 229:351-355
23. Ong TZ, Raymond AA (2002) Risk factors for stroke and predictors of one-month mortality. Singapore Med J 43:517-521
24. Thrift AG, McNeil JJ, Forbes A, Donnan GA (1996) Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke 27:2020-2025
25. Casais P, Luceros AS, Meschengieser S, Fondevila C, Santarelli MT, Lazzari MA (2000) Bleeding risk factors in chronic oral anticoagulation with acenocoumarol. Am J Hematol 63:192-196
26. Dahl T, Abildgaard U, Sandset PM (1995) Long-term anticoagulant therapy in cerebrovascular disease: Does bleeding outweigh the benefit? J Intern Med 237:323-329
27. Gullov AL, Koefoed BG, Petersen P (1994) Bleeding complications to long-term oral anticoagulant therapy. J Thromb Thrombolysis 1:17-25
28. Steffensen FH, Kristensen K, Ejlersen E, Dahlerup JF, Sorensen HT (1997) Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort. J Intern Med 242:497-503
29. White RH, McKittrick T, Takakuwa J, Callahan C, McDonell M, Fihn S (1996) Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics. Arch Intern Med 156:1197-1201
30. Elcano J, Martinez JM, Foncuberta J, Grau E, Felez J, Ruscalleda J (1990) Intracranial hemorrhage in patients undergoing anticoagulant treatment with acenocoumarol. Med Clin (Barc) 94:201-203
31. Azar AJ, Koudstaal PJ, Wintzen AR, van Bergen PF, Jonker JJ, Deckers JW (1996) Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction. Ann Neurol 39:301-307
32. Fogelholm R, Eskola K, Kiminkinen T, Kunnamo I (1992) Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 55:1121-1124
33. Freixa R, Blanch P, Ibernon M, Padro J, Delso J, Sobrepera JL, Salas E, Dos L, Codinach P (2003) Identification of factors responsible for oral over-anticoagulation in outpatients with heart disease. Rev Esp Cardiol 56:65-72
34. Gorter JW (1999) Major bleeding during anticoagulation after cerebral ischemia: Patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 53:1319-1327
35. Gurwitz JH, Goldberg RJ, Holden A, Knapic N, Ansell J (1988) Age-related risks of long-term oral anticoagulant therapy. Arch Intern Med 148:1733-1736
36. Hylek EM, Singer DE (1994) Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120:897-902
37. Landefeld CS, Goldman L (1989) Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy. Am J Med 87:144-152
38. Punthakee X, Doobay J, Anand SS (2002) Oral-anticoagulant-related intracerebral hemorrhage. Thromb Res 108:31-36
39. Selva O'Callaghan A, San Jose Laporte A, Fuentes Camps I, Nicolau Fuste J, Piqueras Carrasco J, Vilardell Tarres M (1997) Hemorrhagic complications and thrombotic phenomena in oral anticoagulation of elderly patients. Rev Clin Esp 197:323-328
40. Van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E (1993) Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 153:1557-1562
41. Fihn SD, McDonell M, Martin D, Henikoff J, Vermes D, Kent D, White RH (1993) Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med 118:511-520
42. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH (1996) The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med 124:970-979
43. Kase CS, Robinson RK, Stein RW, DeWitt LD, Hier DB, Harp DL, Williams JP, Caplan LR, Mohr JP (1985) Anticoagulant-related intracerebral hemorrhage. Neurology 35:943-948
44. Braun S, Chamorro G, Wilson C, Casanegra P, Corbalan R, Iirarrazaval MJ, Kobus C, Valle I (1992) Risk of chronic oral anticoagulant treatment in elderly patients. Rev Med Chil 120:552-558
45. Breen AB, Vaskinn TE, Reikvam A, Skovlund E, Lislevand H, Madsen S (2003) Warfarin treatment and bleeding. Tidsskr Nor Laegeforen 123:1835-1837
46. Sjoblom L, Hardemark HG, Lindgren A, Norrving B, Fahlen M, Samuelsson M, Stigendal L, Stockelberg D, Taghavi A, Wallrup L, Wallvik J (2001) Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: A Swedish multicenter study. Stroke 32:2567-2574
47. Beyth RJ (2001) Hemorrhagic complications of oral anticoagulant therapy. Clin Geriatr Med 17:49-56
48. Saxena R, Kouudstaal P (2004) Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonreumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst Rev
49. Linkins LA, Choi PT, Douketis JD (2003) Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: A meta-analysis. Ann Intern Med 139:893-900
50. Bleeding during antithrombotic therapy in patients with atrial fibrillation (1996) The stroke prevention in atrial fibrillation investigators. Arch Intern Med 156:409-416
51. (2003) ESPRIT Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage. Stroke 34:e45-e46
52. Spektor S, Agus S, Merkin V, Constantini S (2003) Low-dose aspirin prophylaxis and risk of intracranial hemorrhage in patients older than 60 years of age with mild or moderate head injury: A prospective study. J Neurosurg 99:661-665
53. Berwaerts J, Robb OJ, Dykhuizen RS, Webster J (2000) Course, management and outcome of oral-anticoagulant-related intracranial haemorrhages. Scott Med J 45:105-109
54. Cartmill M, Dolan G, Byrne JL, Byrne PO (2000) Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 14:458-461
55. Crowther MA, Donovan D, Harrison, L, McGinnis J, Ginsberg J (1998) Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin. Thromb Haemost 79:1116-1118
56. Fredriksson K, Norrving B, Stromblad LG (1992) Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 23:972-977
57. Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K (1995) Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol 44:438-442
58. Lin J, Hanigan WC, Tarantino M, Wang J (2003) The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: Preliminary findings. J Neurosurg 98:737-740
59. Pindur G, Morsdorf S (1999) The use of prothrombin complex concentrates in the treatment of hemorrhages induced by oral anticoagulation. Thromb Res 95:S57-S61
60. Yasaka M, Sakata T, Minematsu K, Naritomi H (2002) Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res 108:25-30